Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates
14/5 23:10
Journey Medical (DERM) delivered earnings and revenue surprises of 25% and 10.55%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...